Enveric Biosciences (ENVB) Revenue (2014 - 2026)
Enveric Biosciences (ENVB) posted Revenue of $8.48 million for Q3 2020, down 7.3% from $9.15 million a year earlier but up 2.8% from the prior quarter.
Enveric Biosciences (ENVB) Revenue (2014 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2020, Revenue at Enveric Biosciences was $35.41 million, down 13.9% year-over-year; for FY2019, it was $39.91 million, down 7.2% from FY2018.
- Annual Revenue shows a four-year compound annual growth rate of 18.5% (FY2015 to FY2019).
- In prior years, Enveric Biosciences' Revenue was $43 million in FY2018 (-11.5%), $48.59 million in FY2017 (+34.4%), $36.15 million in FY2016 (+78.4%) and $20.26 million in FY2015.
- Quarterly Revenue has run from a low of $6.69 million in Q2 2016 to a high of $12.53 million in Q3 2017 over five years.
- On a year-over-year basis, Revenue has declined in each of the last 12 quarters, with an average decline of 10.3% over the last eight quarters.
- The strongest year-over-year quarter for Revenue in the past five years was Q3 2016, with growth of 125.4%; the weakest was Q2 2020, with a decline of 25.1%.
- According to Business Quant data, Revenue for the three prior quarters was $8.25 million (Q2 2020), $9.6 million (Q1 2020) and $9.06 million (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Enveric Biosciences | 6.08 Mn | -15.56 Mn | - | -292.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -292.00 |
| Mar 31, 2026 | -303.00 |
| Dec 31, 2025 | -250.00 |
| Sep 30, 2025 | 274.00 |
| Jun 30, 2025 | -132.00 |
| Mar 31, 2025 | 3,252.00 |
| Dec 31, 2024 | -225.00 |
| Sep 30, 2024 | -217.00 |
| Jun 30, 2024 | 51,965.00 |
| Mar 31, 2024 | 46,196.00 |
| Dec 31, 2023 | 566.00 |
| Sep 30, 2023 | 2,237.00 |
| Jun 30, 2023 | 916.00 |
| Mar 31, 2023 | -11.00 |
| Dec 31, 2022 | -135.00 |
| Sep 30, 2022 | -308.00 |
| Jun 30, 2022 | -668.00 |
| Sep 30, 2020 | 8.48 Mn |
| Jun 30, 2020 | 8.25 Mn |
| Mar 31, 2020 | 9.60 Mn |
Enveric Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ENVB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();